Is 16:8 Intermittent Fasting a Weight Loss Tool or a Health Cure?

AI Drug Reduces Aging Markers in Lung Disease Trial: What It Means for Healthspan

Understanding Predator Control: Timing Matters in New Zealand's Ecosystems

Intensive Blood Pressure Control Linked to 15% Lower Dementia Risk

What's New?

Must Reads

FDA approves Vertex’s non-opioid painkiller, first new kind of pain medicine in decades

The FDA has approved Vertex Pharmaceuticals' non-opioid painkiller Journavx, marking the first new type of pain medicine approved in decades and offering an alternative to opioids without the risk of addiction.

5 Heart Attack Warning Signs Women Should Never Ignore

Common Food Preservatives Linked to Type 2 Diabetes, Cancer Risk

Early Signs of Multiple Sclerosis: 15 Years Before Onset?

AI Platform Enhances Cancer Patient Access to Clinical Trials

More on medicalnewscorner

Load More